MENU
Pills
LAB TESTS
DON'T LIE!

This is the section of my website that most of the companies in the prostate industry hope you never see! That's because here you find out what is really in these products. Are the companies telling the truth? Which products have strong formulas? Which products are worthless? Is the product you use really any good? How does it stack up against the others? Well you are about to get the answer to those questions that only laboratory analysis can reveal.

The primary laboratory I used is the company Covance. They are widely regarded as the top testing company in the world. They have the best equipment, are incredibly accurate and do a great job.

Covance - Solutions Made Real

I have highlighted the two key scores on each lab report – the Beta-sistosterol score and total sterol score. These are the most important.

Covance - Solutions Made Real

These lab tests cost me over $217,000. But they were worth every penny, because now we know FOR SURE what these products REALLY contain.

Over 170 Reviews and Lab Reports.
Pills
Prostate Pill Report
References
  • 1. Glynn RJ, Campion EW, Bouchard GR, Silbert JE. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol. 1985 Jan;121(1):78-90. PMID 3964994
  • 2. Homma Y, Imajo C, Takahashi S, Kawabe K, Aso Y. Urinary symptoms and urodynamics in a normal elderly population. Scand J Urol Nephrol Suppl. 1994;157:27-30. PMID 7939451
  • 3. Berges RR, Kassen A, Senge T. Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up. BJU Int. 2000 May;85(7):842-6. PMID 10792163
  • 4. Berges RR, Windeler J, Trampisch HJ, Senge T. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Lancet. 1995 Jun 17;345(8964):1529-32. PMID 7540705
  • 5. Klippel KF, Hiltl DM, Schipp B. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group. Br J Urol. 1997 Sep;80(3):427-32. PMID 9313662
  • 6. Wilt TJ, MacDonald R, Ishani A. beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU Int. 1999 Jun;83(9):976-83. PMID 10368239
  • 7. Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J. Beta-sitosterols for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2000;(2):CD001043. PMID 10796740
  • 8. Von Holtz RL, Fink CS, Awad AB. Beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer. 1998;32(1):8-12. PMID 9824850
  • 9. Duan RD. Anticancer compounds and sphingolipid metabolism in the colon. In Vivo. 2005 Jan-Feb;19(1):293-300. PMID 15796189
  • 10. Awad AB, Fink CS, Williams H, Kim U. In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells. Eur J Cancer Prev. 2001 Dec;10(6):507-13. PMID 11916349
  • 11. Awad AB, Gan Y, Fink CS. Effect of beta-sitosterol, a plant sterol, on growth, protein phosphatase 2A, and phospholipase D in LNCaP cells. Nutr Cancer. 2000;36(1):74-8. PMID 10798219
  • 12. Awad AB, Downie A, Fink CS, Kim U. Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice. Anticancer Res. 2000 Mar-Apr;20(2A):821-4. PMID 10810360
  • 13. wad AB, Downie AC, Fink CS. Inhibition of growth and stimulation of apoptosis by beta-sitosterol treatment of MDA-MB-231 human breast cancer cells in culture. Int J Mol Med. 2000 May;5(5):541-5. PMID 10762659
  • 14. Awad AB, Williams H, Fink CS. Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells. Nutr Cancer. 2001;40(2):157-64. PMID 11962251
  • 15. Medizinische Klinik, v.77 (1982), pp. 520
  • 16. Current Therapeutic Research, v. 55 (1994), pp. 776-85
  • 17. Beta-sitosterols for Benign Prostatic Hyperplasia - https://pubmed.ncbi.nlm.nih.gov/10796740/
  • 18. Efficacy and Acceptability of Tadenan (Pygeum Africanum Extract) in the Treatment of Benign Prostatic Hyperplasia (BPH): A Multicentre Trial in Central Europe - https://pubmed.ncbi.nlm.nih.gov/9787978/

*These statements have not been evaluated by the Food and Drug Administration.These products are not intended to diagnose, treat, cure or prevent any disease.

We want to make it perfectly clear that we are not giving or recommending medical advice. This website is intended to be educational and informational only. You should check with a doctor or a qualified licensed health care professional before taking any of the products mentioned on this website. These products are reviewed and rated and recommended based on independent laboratory analysis, survey sheets received from men around the country, discussions with researchers, doctors and natural health industry personnel and based on the websites' operators' personal opinion and should not be viewed as absolute scientific conclusions. All opinions and reviews on this website are the opinion of, and were written by Fred Buckley, the president and owner of Verified Nutrition, the owner and distributor of ProstaGenix. The information contained on this website is intended to educate and inform you of natural products designed to help improve prostate health and not to treat, cure, prevent or modify any disease. Neither Fred Buckley or Digital Health Media, LLC assume any liability for the information contained herein. The publishers of this guide do have a financial interest in some of the products reviewed herein. The mention of any celebrity or other name in this guide does not constitute an endorsement of this guide, or any product mentioned herein.

Larry King is a paid endorser of ProstaGenix